• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Nicholas Robert, MD: The FDA and Education on Biosimilars


Nicholas Robert, MD, medical director of data, evidence and insights at McKesson Life Sciences, discusses the FDA’s role in helping providers become comfortable with biosimilars.


Yes, I think regulatory agencies have a real leadership role to play. They’re, you know, the referee. The government, the FDA, is here to serve the citizens and support effective and safe care. And there is also a role in affordable care, so providing some guidance in terms of efficacy and safety will help pave the way to affordable care. So the FDA has also changed; I think they’re much more responsive to what’s happening. I think they’re a key partner and playing a significant role as we improve care.

Related Videos
Jeffrey Casberg, RPh, MS.
Adam Colborn, JD.
Legal scale weighs profit as greater than medical treatment
Ha Kung Wong, JD.
Ha Kung Wong, JD
Cencora's Corey Ford
Brian Biehn
Chelsee Jensen, PharmD, BCPS
Ryan Haumschild, PharmD, MS, MBA
Related Content
© 2024 MJH Life Sciences

All rights reserved.